Issues in designing flexible trials

Statistics in Medicine

Volumn 22, Issue 6, 2003, Pages 953-969

  Posch, Martin ^a   Bauer, Peter ^a   Brannath, Werner ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adaptive designs; Conditional power; Expected sample size; Inserting interim analyses; Sample size reassessment

Indexed keywords

DRUG;

ANALYTICAL ERROR; CLINICAL STUDY; CLINICAL TRIAL; DOSE RESPONSE; HUMAN; HYPOTHESIS; LINEAR SYSTEM; MEDICAL DECISION MAKING; REVIEW; SAMPLE SIZE; STANDARDIZATION; STATISTICAL ANALYSIS;

CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; HUMANS; RESEARCH DESIGN; SAMPLE SIZE;

EID: 0037473241     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1455     Document Type: Review

References (47)

1. Bauer P. Multistage testing with adaptive designs (with discussion). Biometrie und Informatik in Medizin und Biologie 1989; 20:130-148.
2. Bauer P, Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics 1994; 50:1029-1041.
3. Lehmacher W, Wassmer G. Adaptive sample size calculations in group sequential trials. Biometrics 1999; 55:1286-1290.
4. Cui L, Hung HMJ, Wang S. Modification of sample size in group sequential clinical trials. Biometrics 1999; 55:321-324.
5. Bauer P, Brannath W, Posch M. Flexible two stage designs: an overwiew. Methods of Information in Medicine 2001; 40:117-121.
6. Proschan MA, Hunsberger SA. Designed extension of studies based on conditional power. Biometrics 1995; 51:1315-1324.
7. Posch M, Bauer P. Adaptive two stage designs and the conditional error function. Biometrical Journal 1999; 41:689-696.
8. Wassmer G. Statistische Testverfahren für Gruppensequentielle und Adaptive Pläne in Klinischen Studien. Verlag Alexander Mönch: Köln, Germany, 1999.
9. Jennison C, Turnbull BW. Mid-course sample size modification in clinical trials. Statistics in Medicine 2003; 22:971-993.
10. Fisher LD. Self-designing clinical trils. Statistics in Medicine 1998; 17:1551-1562.
11. Shen Y, Fisher L. Statistical inference for self-designing clinical trials with a one-sided hypothesis. Biometrics 1999; 55:190-197.
12. Müller HH, Schäfer H. Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches. Biometrics 2001; 57:886-891.
13. Brannath W, Posch M, Bauer P. Recursive combination tests. Journal of the American Statistical Association 2002; 97:236-244.
14. Shun Z. Sample size reestimation in clinical trials. Drug Information Journal 2001; 35:1409-1422.
15. Shun Z, Yuan W, Brady WE, Hsu H. Type I error in sample size re-estimations based on observed treatment difference. Statistics in Medicine 2001; 20:497-513.
16. Denne JS. Sample size recalculation using conditional power. Statistics in Medicine 2001; 20:2645-2660.
17. Gould AL. Sample size re-estimation: recent developments and practical considerations. Statistics in Medicine 2001; 20:2625-2643.
18. Friede T, Kieser M. A comparison of methods for adaptive sample size adjustment. Statistics in Medicine 2001; 20:3861-3874.
19. Bauer P, Röhmel J. An adaptive method for establishing a dose response relationship. Statistics in Medicine 1995; 14:1595-1607.
20. Bauer M, Bauer P, Budde M. A simulation program for adaptive two stage designs. Computational Statistics & Data Analysis 1998; 26:351-371.
21. Bauer P, Kieser M. Combining different phases in the development of medical treatments within a single trial. Statistics in Medicine 1999; 18:1833-1848.
22. Friede T, Miller F, Bischoff W, Kieser M. A note on change point estimation in dose-response trials. Computational Statistics and Data Analysis 2001; 37:219-232.
23. Kieser M, Bauer P, Lehmacher W. Inference on multiple endpoints in clinical trials with adaptive interim analyses. Biometrical Journal 1999; 41:261-277.
24. Hommel G. Adaptive modifications of hypotheses after an interim analysis. Biometrical Journal 2001; 43: 581-589.
25. Lang T, Auterith A, Bauer P. Trendtests with adaptive scoring. Biometrical Journal 2000; 42:1007-1020.
26. Neuhäuser M. An adaptive location-scale test. Biometrical Journal 2001; 43:809-819.
27. Kieser M, Schneider B, Friede T. A bootstrap procedure for adaptive selection of the test statistic in flexible two-stage designs. Biometrical Journal 2002; 44:641-652.
28. Wang SJ, Hung HMJ, Tsong Y, Cui L. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials. Statistics in Medicine 2001; 20:1903-1912.
29. Brannath W, Bauer P, Maurer W, Posch M. Sequential tests for noninferiority and superiority. Biometrics 2003 (in press).
30. Banik N, Köhne K, Bauer P. On the power of Fisher's combination test for two stage sampling in the presence of nuisance parameters. Biometrical Journal 1996; 38:25-37.
31. Li G, Shih WJ, Xie T, Lu J. A sample size adjustment procedure for clinical trials based on conditional power. Biostatistics 2002; 3:277-287.
32. Müller HH, Schäfer H. Changing a design during the course of an experiment. 2000.
33. Jennison C, Turnbull BW. Group Sequential Methods with Applications to Clinical Trials. Chapman & Hall/CRC: Boca Raton, 2000.
34. Posch M, Bauer P. Interim analysis and sample size reassessment. Biometrics 2000; 56:1170-1176.
35. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 5:549-556.
36. Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64:191-199.
37. Bauer P, Kieser M. A unifying approach for confidence intervals and testing of equivalence and difference. Biometrika 1996; 83:934-937.
38. Brittain EH, Bailey KR. Optimization of multistage testing times and critical values in clinical trials. Biometrics 1993; 49:763-772.
39. Wald A. Sequential Analysis. Wiley: New York, 1947.
40. Wassmer G, Eisebitt R. Addplan Adaptive Designs - Plans and Analyses, User Manual. Addplan GmbH: 2002.
41. Pocock SJ. Interim analyses for randomized clinical trials: the group sequential approach. Biometrics 1982; 38:153-162.
42. Case LD, Morgan TM, Davis CE. Optimal restricted two-stage designs. Controlled Clinical Trials 1987; 8:146-156.
43. Wang SK, Tsiatis AA. Approximately optimal one-parameter boundaries for group sequential trials. Biometrics 1987; 43:193-199.
44. Wassmer G, Bock W. Tables of δ-class boundaries for group sequential trials. Informatik, Biometrie und Epidemiologie in Medizin und Biometrie 1999; 30:190-194.
45. Tsiatis AA, Metha C. On the inefficiency of the adaptive design for monitoring clinical trials. 2002.
46. + exchange inhibitor Eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Journal of the American College of Cardiology 2001; 38:1644-1651.
47. Zeymer U, Suryapranata H et al. Evaluation of the safety and cardioprotective effects of eniporide, a specific Sodium/Hydrogen exchange inhibitor, given as adjunctive therapy to reperfusion in patients with acute myocardial infarction. Heart Drug 2001; 1:71-76.